Clinical Trial Update: A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib

View source ↗

Summary

The clinical study evaluating changes in early and sustained pain control in adults with axial spondyloarthritis treated with Upadacitinib has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Axial Spondylarthritis (axSpA) | Status: COMPLETED